Treatment of Blood Cancers - Biopharma Companies Building out their Pipeline of Solutions [Yahoo! Finance]
Actinium Pharmaceuticals, Inc. (Delaware) (ATNM)
NASDAQ:AMEX Investor Relations:
ir.actiniumpharma.com
Company Research
Source: Yahoo! Finance
and medical technology stocks releases the second of a two-part series looking at developments for the treatment of blood cancers, including AML, featuring Actinium Pharmaceuticals, Inc (NYSE American: ATNM). Actinium is a leader in the development of Antibody Radiation Conjugates (ARCs) and other targeted radiotherapies. Read the full article on Investorideas https://www.investorideas.com/News/2024/biotech/06180Treatment-of-Blood-Cancers.asp Approximately every 3 minutes, one person in the US is diagnosed with leukemia, lymphoma or myeloma. Approximately every 9 minutes, someone in the US dies from a blood cancer. This statistic represents approximately 157 people each day or more than six people every hour. This data from the Leukemia and Lymphoma Society demonstrates the growing and urgent demand for solutions. Behind the scenes and the data, biopharma stocks are developing their unique approaches to treatment and building a pipeline of potential answers. Actinium Pharmac
Show less
Read more
Impact Snapshot
Event Time:
ATNM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ATNM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ATNM alerts
High impacting Actinium Pharmaceuticals, Inc. (Delaware) news events
Weekly update
A roundup of the hottest topics
ATNM
News
- Is Actinium Pharmaceuticals (ATNM) Outperforming Other Medical Stocks This Year? [Yahoo! Finance]Yahoo! Finance
- Acute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials IncreaseGlobeNewswire
- Acute Myeloid Leukemia is on the Rise as Biotechs Race to Develop Groundbreaking TherapiesGlobeNewswire
- Biopharma Stocks Quest for Solutions for Acute Myeloid Leukemia (AML) [Yahoo! Finance]Yahoo! Finance
- Actinium Presents First Ever Data Demonstrating Actimab-A in Combination with Leading Menin Inhibitors Leads to Anti-Tumor Control and Potent Leukemic Cell Killing in Preclinical Acute Myeloid Leukemia Models at the 2024 EHA Congress [Yahoo! Finance]Yahoo! Finance
ATNM
Earnings
- 8/14/23 - Miss
ATNM
Sec Filings
- 4/26/24 - Form 10-Q
- 3/29/24 - Form S-8
- 3/29/24 - Form 10-K
- ATNM's page on the SEC website